Seeking Alpha
 

CombiMatrix Corporation (CBMX)

- NASDAQ
  • Wed, Aug. 5, 4:26 PM
    • CombiMatrix (NASDAQ:CBMX): Q2 EPS of -$0.13 beats by $0.03.
    • Revenue of $2.55M (+31.4% Y/Y) beats by $0.15M.
    • Press Release
    | Wed, Aug. 5, 4:26 PM | Comment!
  • Thu, May 7, 4:11 PM
    • CombiMatrix (NASDAQ:CBMX): Q1 EPS of -$0.15 beats by $0.01.
    • Revenue of $2.33M (+28.0% Y/Y) beats by $0.03M.
    • Press Release
    | Thu, May 7, 4:11 PM | Comment!
  • Wed, Feb. 25, 4:23 PM
    • CombiMatrix (NASDAQ:CBMX): Q4 EPS of -$0.15 beats by $0.04.
    • Revenue of $2.2M (+25.7% Y/Y) in-line.
    • Press Release
    | Wed, Feb. 25, 4:23 PM | 1 Comment
  • Nov. 4, 2014, 4:31 PM
    • CombiMatrix (NASDAQ:CBMX): Q3 EPS of -$0.23 beats by $0.02.
    • Revenue of $2.06M (+37.3% Y/Y) misses by $0.04M.
    • Press Release
    | Nov. 4, 2014, 4:31 PM | Comment!
  • Oct. 28, 2014, 4:48 PM
    • CombiMatrix (CBMX) will report Q3 results on November 4 after the close. The conference call will begin at 1:30 pm PT/4:30 pm ET.
    • Consensus view is a loss of ($0.25) per share on revenues of $2.1M.
    | Oct. 28, 2014, 4:48 PM | Comment!
  • Aug. 6, 2014, 4:44 PM
    • CombiMatrix (NASDAQ:CBMX): Q2 EPS of -$0.23 misses by $0.04.
    • Revenue of $1.9M (+26.7% Y/Y) in-line.
    • Shares +1.9%.
    • Press Release
    | Aug. 6, 2014, 4:44 PM | Comment!
  • Aug. 6, 2014, 4:31 PM
    • CombiMatrix Corp. (CBMX +1.4%) Q2 results: Revenues: $1.9M (+29.4%); Operating Expenses: $4.6M (+52.3%); Operating Loss: ($2.7M) (-74.6%); Net Loss: ($2.6M) (-402.7%); Loss Per Share: ($0.23) (+52.1%); Quick Assets: $10.1M (-27.9%).
    • No guidance given.
    | Aug. 6, 2014, 4:31 PM | Comment!
  • May 7, 2014, 10:02 AM
    • CombiMatrix (CBMX -2.6%) revenues: $1.8M (+12.5%); microarray: $1.1M (+31.6%); operating loss: ($2M) (-25%); net loss: ($2M) (-186%); loss/share: ($0.18) (+69.5%); quick assets (ex-A/R): $12.5M (-10.7%).
    • Prenatal test volume: 737 (+59.9%).
    | May 7, 2014, 10:02 AM | Comment!
  • May 7, 2014, 9:21 AM
    | May 7, 2014, 9:21 AM | Comment!
  • Feb. 19, 2014, 6:05 AM
    • CombiMatrix (CBMX): Q4 Net Loss of -$1.81M.
    • Revenue of $1.75M (+18% Y/Y).
    • Press Release
    | Feb. 19, 2014, 6:05 AM | Comment!
  • Aug. 7, 2013, 7:48 AM
    • CombiMatrix (CBMX): Q2 EPS of -$0.03.
    • Revenue of $1.5M. (PR)
    | Aug. 7, 2013, 7:48 AM | Comment!
  • Feb. 27, 2013, 2:44 PM
    CombiMatrix (CBMX -21%) gets slammed after reportingg Q4 revenue that was up 18% Y/Y on higher revenues from its core prenatal testing markets, which grew by 161% on increased billable test volumes. However, net losses soared on non-cash warrant derivative charges as a result of issuing warrants to certain investors in the Company's Series A Preferred Stock financing.
    | Feb. 27, 2013, 2:44 PM | 2 Comments
  • Feb. 27, 2013, 6:14 AM
    CombiMatrix (CBMX): Q4 EPS of -$3.31. Revenue of $1.5M (+18% Y/Y). (PR)
    | Feb. 27, 2013, 6:14 AM | Comment!
Visit Seeking Alpha's
CBMX vs. ETF Alternatives
Company Description
CombiMatrix Corp is a molecular diagnostics company that operates in the field of genetic analysis and molecular diagnostics.
Sector: Healthcare
Industry: Biotechnology
Country: United States